Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone Marrow Diseases | 36 | 2024 | 233 | 7.980 |
Why?
|
Exocrine Pancreatic Insufficiency | 18 | 2024 | 86 | 4.530 |
Why?
|
Myelodysplastic Syndromes | 22 | 2023 | 1394 | 4.040 |
Why?
|
Lipomatosis | 16 | 2024 | 112 | 3.950 |
Why?
|
Anemia, Aplastic | 14 | 2023 | 230 | 3.330 |
Why?
|
Fanconi Anemia | 18 | 2023 | 324 | 2.420 |
Why?
|
Germ-Line Mutation | 18 | 2022 | 1858 | 2.190 |
Why?
|
Myeloproliferative Disorders | 7 | 2023 | 613 | 2.110 |
Why?
|
Leukemia, Myeloid, Acute | 13 | 2024 | 3613 | 1.550 |
Why?
|
Anemia, Diamond-Blackfan | 11 | 2024 | 138 | 1.480 |
Why?
|
Neutropenia | 10 | 2024 | 884 | 1.440 |
Why?
|
Leukemia | 7 | 2022 | 1523 | 1.370 |
Why?
|
Hematologic Neoplasms | 7 | 2023 | 1896 | 1.350 |
Why?
|
Bone Marrow | 13 | 2022 | 2909 | 1.240 |
Why?
|
Ribosomes | 7 | 2021 | 501 | 1.090 |
Why?
|
Proto-Oncogene Proteins c-ets | 3 | 2017 | 313 | 1.090 |
Why?
|
Genetic Diseases, Inborn | 7 | 2016 | 605 | 1.070 |
Why?
|
Hematopoiesis | 11 | 2022 | 2049 | 0.880 |
Why?
|
Proteins | 13 | 2020 | 6034 | 0.850 |
Why?
|
Pancreatic Diseases | 3 | 2018 | 343 | 0.830 |
Why?
|
Memory | 14 | 2001 | 2187 | 0.790 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 4 | 2023 | 359 | 0.770 |
Why?
|
Hematologic Diseases | 2 | 2023 | 496 | 0.750 |
Why?
|
Telomerase | 4 | 2022 | 745 | 0.730 |
Why?
|
Antilymphocyte Serum | 4 | 2019 | 487 | 0.730 |
Why?
|
Genetic Predisposition to Disease | 13 | 2022 | 17872 | 0.720 |
Why?
|
Hematology | 1 | 2024 | 244 | 0.710 |
Why?
|
Genetic Testing | 5 | 2019 | 3538 | 0.710 |
Why?
|
Awards and Prizes | 1 | 2024 | 360 | 0.670 |
Why?
|
Blood Coagulation Disorders, Inherited | 1 | 2019 | 19 | 0.640 |
Why?
|
Cyclosporine | 2 | 2019 | 778 | 0.630 |
Why?
|
Dyskeratosis Congenita | 7 | 2019 | 73 | 0.620 |
Why?
|
Blood Platelet Disorders | 1 | 2019 | 60 | 0.610 |
Why?
|
Telomere | 3 | 2022 | 941 | 0.580 |
Why?
|
Pancreas, Exocrine | 2 | 2017 | 48 | 0.570 |
Why?
|
Thrombocytopenia | 5 | 2019 | 1179 | 0.550 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 232 | 0.550 |
Why?
|
Repressor Proteins | 3 | 2017 | 2985 | 0.540 |
Why?
|
eIF-2 Kinase | 1 | 2017 | 145 | 0.530 |
Why?
|
Pancytopenia | 3 | 2023 | 102 | 0.530 |
Why?
|
Mutation | 24 | 2024 | 30044 | 0.530 |
Why?
|
Hematopoietic Stem Cell Transplantation | 12 | 2024 | 5670 | 0.510 |
Why?
|
Leukocyte Elastase | 3 | 2024 | 114 | 0.510 |
Why?
|
Thrombopoietin | 1 | 2017 | 226 | 0.490 |
Why?
|
Bone Marrow Transplantation | 4 | 2022 | 2693 | 0.480 |
Why?
|
Syndrome | 13 | 2023 | 3268 | 0.480 |
Why?
|
Metformin | 1 | 2022 | 907 | 0.470 |
Why?
|
Bone Marrow Neoplasms | 1 | 2014 | 101 | 0.450 |
Why?
|
GATA2 Transcription Factor | 3 | 2021 | 158 | 0.440 |
Why?
|
Child | 42 | 2024 | 80156 | 0.430 |
Why?
|
Hematopoietic Stem Cells | 11 | 2022 | 3396 | 0.430 |
Why?
|
Ribosome Subunits | 1 | 2012 | 4 | 0.430 |
Why?
|
Child, Preschool | 26 | 2024 | 42251 | 0.430 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2015 | 226 | 0.420 |
Why?
|
Humans | 142 | 2024 | 761326 | 0.410 |
Why?
|
Genomic Instability | 5 | 2016 | 709 | 0.410 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 1549 | 0.390 |
Why?
|
Brain Damage, Chronic | 6 | 1998 | 267 | 0.380 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 5 | 2018 | 146 | 0.370 |
Why?
|
Pedigree | 10 | 2019 | 4589 | 0.370 |
Why?
|
Infant | 23 | 2024 | 36202 | 0.360 |
Why?
|
Mental Processes | 3 | 2000 | 244 | 0.350 |
Why?
|
Codon, Nonsense | 2 | 2024 | 285 | 0.350 |
Why?
|
Amnesia | 9 | 1992 | 255 | 0.340 |
Why?
|
Lymphoma | 1 | 2019 | 1901 | 0.330 |
Why?
|
Bone Marrow Cells | 5 | 2020 | 2416 | 0.330 |
Why?
|
Cues | 7 | 2001 | 875 | 0.320 |
Why?
|
Cell Cycle Proteins | 4 | 2024 | 3448 | 0.310 |
Why?
|
Young Adult | 25 | 2024 | 59196 | 0.310 |
Why?
|
Chromosome Deletion | 4 | 2019 | 1387 | 0.310 |
Why?
|
Disease Susceptibility | 3 | 2023 | 1791 | 0.300 |
Why?
|
Anemia, Sideroblastic | 2 | 2021 | 109 | 0.300 |
Why?
|
Immunosuppressive Agents | 4 | 2020 | 4173 | 0.300 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2248 | 0.300 |
Why?
|
Induced Pluripotent Stem Cells | 4 | 2023 | 1861 | 0.290 |
Why?
|
Adolescent | 30 | 2023 | 88305 | 0.290 |
Why?
|
RNA, Ribosomal | 2 | 2013 | 227 | 0.290 |
Why?
|
Germ Cells | 2 | 2023 | 634 | 0.280 |
Why?
|
Disease Management | 4 | 2024 | 2504 | 0.280 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3611 | 0.270 |
Why?
|
Health Care Surveys | 1 | 2013 | 2426 | 0.270 |
Why?
|
Phenotype | 12 | 2024 | 16603 | 0.270 |
Why?
|
Mental Recall | 12 | 2001 | 1214 | 0.260 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2020 | 628 | 0.260 |
Why?
|
Adult | 49 | 2024 | 221122 | 0.250 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2811 | 0.250 |
Why?
|
Busulfan | 2 | 2017 | 258 | 0.250 |
Why?
|
Genetic Diseases, X-Linked | 2 | 2021 | 386 | 0.240 |
Why?
|
Cell Nucleolus | 1 | 2005 | 156 | 0.240 |
Why?
|
De Lange Syndrome | 1 | 2024 | 21 | 0.230 |
Why?
|
Anemia, Macrocytic | 2 | 2016 | 53 | 0.230 |
Why?
|
Male | 54 | 2024 | 360621 | 0.230 |
Why?
|
Female | 59 | 2024 | 392485 | 0.220 |
Why?
|
Granulocyte Colony-Stimulating Factor | 3 | 2017 | 629 | 0.220 |
Why?
|
Chromosomes, Human, Pair 7 | 3 | 2019 | 310 | 0.220 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2022 | 25 | 0.210 |
Why?
|
North America | 3 | 2021 | 1275 | 0.210 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2022 | 88 | 0.200 |
Why?
|
Blotting, Western | 2 | 2016 | 5034 | 0.200 |
Why?
|
Psychology | 1 | 2024 | 356 | 0.200 |
Why?
|
Mutation, Missense | 3 | 2016 | 2570 | 0.200 |
Why?
|
Transplantation Conditioning | 3 | 2023 | 1590 | 0.190 |
Why?
|
Septins | 1 | 2021 | 49 | 0.190 |
Why?
|
Chromosome Aberrations | 3 | 2019 | 1771 | 0.190 |
Why?
|
Siblings | 3 | 2016 | 825 | 0.190 |
Why?
|
Genotype | 7 | 2021 | 12982 | 0.190 |
Why?
|
Genomics | 3 | 2022 | 5817 | 0.190 |
Why?
|
Inflammation | 2 | 2020 | 10760 | 0.180 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2020 | 44 | 0.180 |
Why?
|
Alcohol Amnestic Disorder | 8 | 1992 | 35 | 0.180 |
Why?
|
Signal Detection, Psychological | 1 | 2000 | 84 | 0.180 |
Why?
|
Karyotyping | 3 | 2019 | 1171 | 0.180 |
Why?
|
Vocabulary | 1 | 2001 | 165 | 0.180 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2021 | 158 | 0.170 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2020 | 187 | 0.170 |
Why?
|
Biology | 1 | 2022 | 289 | 0.170 |
Why?
|
Social Facilitation | 1 | 1999 | 31 | 0.170 |
Why?
|
Consensus | 3 | 2024 | 3122 | 0.170 |
Why?
|
Family Health | 3 | 2017 | 1257 | 0.170 |
Why?
|
Endocrine System | 1 | 2020 | 114 | 0.160 |
Why?
|
UDPglucose 4-Epimerase | 1 | 2019 | 14 | 0.160 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2023 | 3638 | 0.160 |
Why?
|
Smad2 Protein | 1 | 2019 | 145 | 0.160 |
Why?
|
Infant, Newborn | 10 | 2021 | 26211 | 0.160 |
Why?
|
Linguistics | 1 | 1999 | 108 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11735 | 0.160 |
Why?
|
Multiple Myeloma | 1 | 2017 | 5146 | 0.160 |
Why?
|
HEK293 Cells | 2 | 2019 | 4280 | 0.160 |
Why?
|
Cells, Cultured | 10 | 2022 | 18962 | 0.160 |
Why?
|
Phosphorylation | 3 | 2019 | 8312 | 0.160 |
Why?
|
Ribosomal Proteins | 2 | 2016 | 371 | 0.160 |
Why?
|
Aeropyrum | 1 | 2017 | 3 | 0.150 |
Why?
|
Protein Biosynthesis | 2 | 2017 | 2114 | 0.150 |
Why?
|
Neoplasms | 8 | 2023 | 22158 | 0.150 |
Why?
|
Verbal Behavior | 2 | 1998 | 335 | 0.150 |
Why?
|
Eukaryotic Initiation Factors | 2 | 2021 | 85 | 0.150 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2019 | 117 | 0.150 |
Why?
|
Signal Recognition Particle | 1 | 2017 | 47 | 0.150 |
Why?
|
Galactosemias | 1 | 2019 | 124 | 0.150 |
Why?
|
Peroxiredoxins | 1 | 2017 | 51 | 0.150 |
Why?
|
Transforming Growth Factor beta | 3 | 2020 | 1959 | 0.140 |
Why?
|
Inflammasomes | 1 | 2022 | 525 | 0.140 |
Why?
|
Pregnancy Complications, Hematologic | 2 | 2017 | 179 | 0.140 |
Why?
|
Cell Polarity | 1 | 2020 | 637 | 0.140 |
Why?
|
Cognition | 4 | 2000 | 6987 | 0.140 |
Why?
|
Base Sequence | 3 | 2017 | 12449 | 0.140 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2022 | 1135 | 0.140 |
Why?
|
Stromal Cells | 2 | 2012 | 1330 | 0.140 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2017 | 95 | 0.140 |
Why?
|
Gene Knockdown Techniques | 2 | 2012 | 1611 | 0.140 |
Why?
|
Prognosis | 7 | 2020 | 29588 | 0.130 |
Why?
|
Fanconi Anemia Complementation Group A Protein | 2 | 2020 | 50 | 0.130 |
Why?
|
Models, Psychological | 1 | 2000 | 828 | 0.130 |
Why?
|
Microtubules | 2 | 2014 | 1074 | 0.130 |
Why?
|
Nuclear Proteins | 4 | 2013 | 5794 | 0.130 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2016 | 225 | 0.120 |
Why?
|
Middle Aged | 28 | 2023 | 220774 | 0.120 |
Why?
|
Globins | 1 | 2016 | 403 | 0.120 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39108 | 0.120 |
Why?
|
Sequence Analysis, DNA | 2 | 2016 | 4740 | 0.120 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2016 | 1058 | 0.120 |
Why?
|
Tumor Suppressor Proteins | 3 | 2017 | 2804 | 0.120 |
Why?
|
Mesenchymal Stem Cells | 3 | 2022 | 1642 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2022 | 2870 | 0.120 |
Why?
|
Cerebellar Ataxia | 1 | 2016 | 150 | 0.120 |
Why?
|
Microfluidics | 1 | 2020 | 653 | 0.120 |
Why?
|
Neuropsychological Tests | 9 | 1998 | 7045 | 0.120 |
Why?
|
Lymphocytes | 1 | 2002 | 2610 | 0.120 |
Why?
|
Exons | 2 | 2024 | 2392 | 0.120 |
Why?
|
Megakaryocytes | 1 | 2019 | 566 | 0.120 |
Why?
|
Protein Processing, Post-Translational | 1 | 2002 | 1974 | 0.120 |
Why?
|
BRCA1 Protein | 2 | 2018 | 1155 | 0.120 |
Why?
|
Blood Donors | 1 | 2016 | 345 | 0.120 |
Why?
|
Heme | 1 | 2016 | 313 | 0.110 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 1405 | 0.110 |
Why?
|
Protein Isoforms | 1 | 2019 | 1698 | 0.110 |
Why?
|
Pancreas | 2 | 2013 | 1689 | 0.110 |
Why?
|
Autophagy | 1 | 2022 | 1321 | 0.110 |
Why?
|
Ribonucleoproteins, Small Nucleolar | 1 | 2013 | 7 | 0.110 |
Why?
|
Receptors, Fc | 1 | 2017 | 535 | 0.110 |
Why?
|
Arteriovenous Fistula | 1 | 2017 | 319 | 0.110 |
Why?
|
HeLa Cells | 3 | 2015 | 3097 | 0.110 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2015 | 398 | 0.110 |
Why?
|
Ubiquitination | 1 | 2018 | 1006 | 0.110 |
Why?
|
DNA Mutational Analysis | 5 | 2017 | 4108 | 0.110 |
Why?
|
Homozygote | 1 | 2018 | 1796 | 0.110 |
Why?
|
Awareness | 2 | 1988 | 647 | 0.110 |
Why?
|
Affect | 1 | 2001 | 1485 | 0.110 |
Why?
|
Protein Binding | 3 | 2012 | 9351 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1093 | 0.110 |
Why?
|
Cell Line | 6 | 2021 | 15599 | 0.110 |
Why?
|
DEAD-box RNA Helicases | 1 | 2015 | 383 | 0.100 |
Why?
|
Graft vs Host Disease | 2 | 2023 | 3030 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2724 | 0.100 |
Why?
|
Common Variable Immunodeficiency | 1 | 2013 | 102 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2009 | 611 | 0.100 |
Why?
|
Models, Molecular | 3 | 2017 | 5439 | 0.100 |
Why?
|
Frontal Lobe | 1 | 1998 | 1420 | 0.090 |
Why?
|
RNA, Small Interfering | 2 | 2012 | 3428 | 0.090 |
Why?
|
Paired-Associate Learning | 3 | 1990 | 54 | 0.090 |
Why?
|
Transplantation, Homologous | 3 | 2023 | 4810 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8526 | 0.090 |
Why?
|
Sequence Analysis, RNA | 2 | 2019 | 2019 | 0.090 |
Why?
|
Pulmonary Veins | 1 | 2017 | 746 | 0.090 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2011 | 228 | 0.090 |
Why?
|
Genes, Reporter | 1 | 2015 | 1528 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2193 | 0.090 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2014 | 617 | 0.090 |
Why?
|
Transfection | 2 | 2012 | 5776 | 0.090 |
Why?
|
Caregivers | 1 | 2022 | 2235 | 0.090 |
Why?
|
Alleles | 3 | 2022 | 6909 | 0.090 |
Why?
|
Mitomycin | 2 | 2018 | 263 | 0.080 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 979 | 0.080 |
Why?
|
RNA, Untranslated | 1 | 2013 | 459 | 0.080 |
Why?
|
Attention | 5 | 2001 | 2395 | 0.080 |
Why?
|
Dexamethasone | 1 | 2017 | 1946 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2023 | 80575 | 0.080 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6128 | 0.080 |
Why?
|
Survival Rate | 2 | 2020 | 12710 | 0.080 |
Why?
|
Models, Biological | 4 | 2014 | 9468 | 0.080 |
Why?
|
Bone Marrow Examination | 1 | 2009 | 154 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 1 | 2017 | 3734 | 0.080 |
Why?
|
Disease Progression | 2 | 2019 | 13500 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4244 | 0.080 |
Why?
|
Molecular Sequence Data | 3 | 2015 | 17640 | 0.080 |
Why?
|
Pulmonary Artery | 1 | 2017 | 1938 | 0.080 |
Why?
|
Blood Platelets | 1 | 2019 | 2481 | 0.070 |
Why?
|
Aged | 15 | 2023 | 169179 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3792 | 0.070 |
Why?
|
Fanconi Anemia Complementation Group G Protein | 1 | 2007 | 18 | 0.070 |
Why?
|
Fanconi Anemia Complementation Group C Protein | 1 | 2007 | 21 | 0.070 |
Why?
|
Chromosome Breakage | 2 | 2011 | 159 | 0.070 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13446 | 0.070 |
Why?
|
Cohort Studies | 2 | 2022 | 41440 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2012 | 983 | 0.070 |
Why?
|
Lymphatic Vessels | 1 | 2011 | 358 | 0.070 |
Why?
|
Antigens, CD34 | 2 | 2020 | 658 | 0.070 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2007 | 110 | 0.070 |
Why?
|
Dactinomycin | 1 | 2007 | 304 | 0.070 |
Why?
|
Animals | 15 | 2022 | 168388 | 0.070 |
Why?
|
Genetic Variation | 2 | 2021 | 6571 | 0.070 |
Why?
|
Risk | 1 | 2019 | 9605 | 0.070 |
Why?
|
Anemia | 1 | 2016 | 1508 | 0.070 |
Why?
|
Pregnancy Outcome | 1 | 2017 | 2920 | 0.070 |
Why?
|
Endopeptidases | 1 | 2010 | 773 | 0.070 |
Why?
|
HLA Antigens | 2 | 2022 | 1371 | 0.070 |
Why?
|
Decision Making | 1 | 2020 | 3929 | 0.070 |
Why?
|
Genes, Recessive | 1 | 2009 | 628 | 0.070 |
Why?
|
DNA Damage | 4 | 2020 | 2442 | 0.070 |
Why?
|
Proteomics | 1 | 2020 | 3843 | 0.070 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2009 | 245 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7582 | 0.070 |
Why?
|
Semantics | 4 | 1998 | 601 | 0.060 |
Why?
|
Cell Line, Transformed | 2 | 2007 | 868 | 0.060 |
Why?
|
Erythropoiesis | 2 | 2016 | 682 | 0.060 |
Why?
|
Family | 1 | 2016 | 3197 | 0.060 |
Why?
|
Pancreatitis, Chronic | 1 | 2008 | 289 | 0.060 |
Why?
|
Prefrontal Cortex | 1 | 1995 | 2219 | 0.060 |
Why?
|
Signal Transduction | 4 | 2019 | 23427 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6525 | 0.060 |
Why?
|
Lymphedema | 1 | 2011 | 525 | 0.060 |
Why?
|
Medical History Taking | 1 | 2009 | 773 | 0.060 |
Why?
|
Ubiquitin | 2 | 2016 | 838 | 0.060 |
Why?
|
Genetic Counseling | 1 | 2009 | 627 | 0.060 |
Why?
|
United States | 3 | 2024 | 72317 | 0.060 |
Why?
|
Pregnancy | 4 | 2017 | 29858 | 0.060 |
Why?
|
Interphase | 1 | 2005 | 228 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9275 | 0.060 |
Why?
|
Vidarabine | 2 | 2017 | 336 | 0.060 |
Why?
|
Cytoplasm | 2 | 2008 | 1511 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4696 | 0.060 |
Why?
|
Perception | 2 | 2001 | 1197 | 0.060 |
Why?
|
RNA | 2 | 2017 | 2723 | 0.060 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2015 | 2119 | 0.060 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2024 | 141 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7389 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2020 | 10431 | 0.050 |
Why?
|
Cell Differentiation | 5 | 2020 | 11531 | 0.050 |
Why?
|
Mass Screening | 1 | 2019 | 5428 | 0.050 |
Why?
|
Gene Frequency | 2 | 2021 | 3639 | 0.050 |
Why?
|
Chromosomal Instability | 1 | 2003 | 178 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2015 | 3816 | 0.050 |
Why?
|
Physical Examination | 1 | 2009 | 1254 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1262 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2021 | 22124 | 0.050 |
Why?
|
Echocardiography | 1 | 2015 | 4991 | 0.050 |
Why?
|
Epoxy Compounds | 1 | 2002 | 137 | 0.050 |
Why?
|
Tetraploidy | 1 | 2021 | 28 | 0.050 |
Why?
|
Acute Disease | 2 | 2023 | 7238 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5297 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2008 | 2909 | 0.050 |
Why?
|
Registries | 2 | 2017 | 8223 | 0.050 |
Why?
|
DNA Repair | 2 | 2023 | 2044 | 0.050 |
Why?
|
Pluripotent Stem Cells | 1 | 2008 | 800 | 0.050 |
Why?
|
HLA-B Antigens | 1 | 2022 | 331 | 0.050 |
Why?
|
Abnormalities, Multiple | 1 | 2009 | 1424 | 0.050 |
Why?
|
Androgens | 1 | 2009 | 1286 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4877 | 0.050 |
Why?
|
Mosaicism | 1 | 2004 | 475 | 0.050 |
Why?
|
Optical Illusions | 1 | 2001 | 40 | 0.050 |
Why?
|
Mice | 8 | 2022 | 81474 | 0.050 |
Why?
|
Apoptosis | 1 | 2017 | 9474 | 0.050 |
Why?
|
Multiprotein Complexes | 1 | 2007 | 1121 | 0.050 |
Why?
|
Genes, BRCA1 | 1 | 2004 | 764 | 0.050 |
Why?
|
Genes, BRCA2 | 1 | 2003 | 601 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2002 | 442 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2021 | 2911 | 0.040 |
Why?
|
Retroviridae | 1 | 2002 | 850 | 0.040 |
Why?
|
Growth Differentiation Factors | 1 | 2020 | 99 | 0.040 |
Why?
|
DNA-Binding Proteins | 3 | 2016 | 9605 | 0.040 |
Why?
|
Protein Transport | 1 | 2005 | 1967 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 370 | 0.040 |
Why?
|
Orientation | 1 | 2001 | 321 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2002 | 1992 | 0.040 |
Why?
|
Cognition Disorders | 1 | 1993 | 3979 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2002 | 732 | 0.040 |
Why?
|
Fetal Hemoglobin | 1 | 2021 | 345 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2022 | 1250 | 0.040 |
Why?
|
Zebrafish | 2 | 2022 | 3005 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2024 | 726 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2008 | 2821 | 0.040 |
Why?
|
Pyrococcus horikoshii | 1 | 2017 | 5 | 0.040 |
Why?
|
Verbal Learning | 2 | 1992 | 463 | 0.040 |
Why?
|
Volition | 1 | 1998 | 62 | 0.040 |
Why?
|
Dominance, Cerebral | 2 | 1998 | 623 | 0.040 |
Why?
|
Lactation Disorders | 1 | 2017 | 14 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2018 | 21009 | 0.040 |
Why?
|
DNA Helicases | 1 | 2023 | 851 | 0.040 |
Why?
|
Galactose | 1 | 2019 | 297 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2017 | 64645 | 0.040 |
Why?
|
Granulocytes | 1 | 2019 | 552 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23981 | 0.040 |
Why?
|
Mutagens | 2 | 2011 | 179 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2008 | 1726 | 0.040 |
Why?
|
Heterozygote | 1 | 2024 | 2803 | 0.030 |
Why?
|
Virulence | 1 | 2021 | 1302 | 0.030 |
Why?
|
Concept Formation | 1 | 1998 | 161 | 0.030 |
Why?
|
Cell Cycle | 1 | 2005 | 2930 | 0.030 |
Why?
|
Electroconvulsive Therapy | 3 | 1987 | 500 | 0.030 |
Why?
|
Monocytes | 2 | 2019 | 2573 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2017 | 573 | 0.030 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2016 | 97 | 0.030 |
Why?
|
Cell Survival | 2 | 2020 | 5792 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1320 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1355 | 0.030 |
Why?
|
Informed Consent | 1 | 2022 | 1008 | 0.030 |
Why?
|
Rad51 Recombinase | 1 | 2016 | 189 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2021 | 1393 | 0.030 |
Why?
|
Penetrance | 1 | 2017 | 388 | 0.030 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2016 | 200 | 0.030 |
Why?
|
Occipital Lobe | 1 | 1997 | 374 | 0.030 |
Why?
|
Fetal Death | 1 | 2017 | 435 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2020 | 435 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2020 | 841 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 2648 | 0.030 |
Why?
|
Liver | 1 | 2011 | 7531 | 0.030 |
Why?
|
Voice | 1 | 1998 | 268 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 2018 | 686 | 0.030 |
Why?
|
Erythroid Cells | 1 | 2016 | 238 | 0.030 |
Why?
|
Adenosine Deaminase | 1 | 2016 | 251 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2017 | 728 | 0.030 |
Why?
|
Dioxygenases | 1 | 2016 | 345 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2014 | 181 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2016 | 662 | 0.030 |
Why?
|
Myeloablative Agonists | 1 | 2014 | 209 | 0.030 |
Why?
|
Chromosome Segregation | 1 | 2014 | 235 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7597 | 0.030 |
Why?
|
Face | 1 | 1999 | 1026 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2002 | 3393 | 0.030 |
Why?
|
Point Mutation | 1 | 2017 | 1595 | 0.030 |
Why?
|
Abortion, Spontaneous | 1 | 2017 | 533 | 0.030 |
Why?
|
Perfusion | 1 | 2017 | 1374 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 2897 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2468 | 0.020 |
Why?
|
Infertility, Female | 1 | 2017 | 760 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12972 | 0.020 |
Why?
|
Tacrolimus | 1 | 2014 | 733 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2016 | 2382 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2022 | 3108 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 1994 | 761 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5363 | 0.020 |
Why?
|
Lymphangiogenesis | 1 | 2011 | 172 | 0.020 |
Why?
|
Cell Lineage | 1 | 2019 | 2556 | 0.020 |
Why?
|
Memory Disorders | 1 | 1997 | 1198 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2013 | 621 | 0.020 |
Why?
|
Protein Conformation | 1 | 2017 | 3969 | 0.020 |
Why?
|
Hypoxia, Brain | 2 | 1987 | 138 | 0.020 |
Why?
|
Temporal Lobe | 1 | 1997 | 1695 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2011 | 385 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3381 | 0.020 |
Why?
|
Visual Perception | 1 | 1998 | 1385 | 0.020 |
Why?
|
Mitosis | 1 | 2014 | 1186 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2013 | 753 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5247 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1998 | 6231 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58946 | 0.020 |
Why?
|
Leukocytes | 1 | 2017 | 2029 | 0.020 |
Why?
|
Age of Onset | 1 | 2015 | 3303 | 0.020 |
Why?
|
Arabidopsis Proteins | 1 | 2010 | 264 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4567 | 0.020 |
Why?
|
Calibration | 1 | 2011 | 818 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2013 | 664 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2137 | 0.020 |
Why?
|
Methotrexate | 1 | 2014 | 1720 | 0.020 |
Why?
|
Alcoholism | 3 | 1987 | 1973 | 0.020 |
Why?
|
Wounds, Stab | 1 | 1987 | 72 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3777 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8632 | 0.020 |
Why?
|
Reading | 1 | 1990 | 529 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6815 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7999 | 0.020 |
Why?
|
Graft Survival | 1 | 2017 | 3818 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1833 | 0.020 |
Why?
|
Learning | 1 | 1995 | 1740 | 0.020 |
Why?
|
Brain Ischemia | 3 | 1988 | 3048 | 0.020 |
Why?
|
Reference Values | 1 | 1993 | 4921 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5866 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1967 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1336 | 0.020 |
Why?
|
Sex Factors | 1 | 1998 | 10551 | 0.010 |
Why?
|
DNA | 1 | 2018 | 7216 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4509 | 0.010 |
Why?
|
Sepsis | 1 | 2017 | 2587 | 0.010 |
Why?
|
Erythrocyte Transfusion | 1 | 2008 | 565 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15835 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36430 | 0.010 |
Why?
|
Congenital Abnormalities | 1 | 2008 | 709 | 0.010 |
Why?
|
Psychometrics | 1 | 1993 | 3064 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12122 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11900 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9319 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2011 | 22154 | 0.010 |
Why?
|
Iron | 1 | 2011 | 1792 | 0.010 |
Why?
|
Brain Stem Neoplasms | 1 | 2003 | 190 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2832 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2008 | 16966 | 0.010 |
Why?
|
Wilms Tumor | 1 | 2003 | 379 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3687 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9534 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2011 | 3577 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2008 | 2163 | 0.010 |
Why?
|
Judgment | 1 | 2001 | 273 | 0.010 |
Why?
|
Medulloblastoma | 1 | 2003 | 678 | 0.010 |
Why?
|
Reaction Time | 2 | 1998 | 2080 | 0.010 |
Why?
|
Lung | 1 | 2017 | 9994 | 0.010 |
Why?
|
Fibroblasts | 1 | 2008 | 4139 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6236 | 0.010 |
Why?
|
Language Tests | 1 | 1997 | 190 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11070 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2389 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15879 | 0.010 |
Why?
|
Brain Injuries | 1 | 1987 | 2053 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8997 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2011 | 20092 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2007 | 14409 | 0.010 |
Why?
|
Algorithms | 1 | 2011 | 14025 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 54405 | 0.010 |
Why?
|
Language | 1 | 1998 | 1539 | 0.000 |
Why?
|
Kidney Neoplasms | 1 | 2003 | 4246 | 0.000 |
Why?
|
Wechsler Scales | 1 | 1987 | 257 | 0.000 |
Why?
|
Memory, Short-Term | 1 | 1990 | 982 | 0.000 |
Why?
|
Intelligence | 1 | 1987 | 924 | 0.000 |
Why?
|
Speech Perception | 1 | 1985 | 507 | 0.000 |
Why?
|
Pattern Recognition, Visual | 1 | 1985 | 820 | 0.000 |
Why?
|
Depressive Disorder | 1 | 1985 | 3728 | 0.000 |
Why?
|